Pacira Pharmaceuticals reported $36.07M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.78M 0.45M
Aerie Pharmaceuticals AERI:US $ 6.78M 0.71M
Amerisourcebergen ABC:US $ 55486.2M 2082.25M
Astellas Pharma 4503:JP Y 58915M 10444M
Bristol Myers Squibb BMY:US $ 2471M 115M
Coherus Biosciences CHRS:US $ 9.37M 2.73M
Depomed DEPO:US $ 4.2M 0.7M
Endo International Ordinary Shares ENDP:US $ 179.76M 42.71M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Horizon Pharma HZNP:US $ 215.06M 26.45M
JAZZ PHA JAZZ:US $ 115.28M 20.87M
Johnson & Johnson JNJ:US $ 7598M 357M
Lannett LCI:US $ 75.28M 5.52M
Ligand Pharmaceuticals LGND:US $ 4.7M 7.28M
Nektar Therapeutics NKTR:US $ 5.32M 0.85M
Pacira Pharmaceuticals PCRX:US $ 36.07M 2.93M
Perrigo Ordinary Shares PRGO:US $ 736.7M 5.8M
Pfizer PFE:US $ 10010M 399M
Revance Therapeutics RVNC:US $ 7.89M 12K
Supernus Pharmaceuticals SUPN:US $ 17.93M 0.94M
Teva Pharmaceutical TEVA:IT 1.86B 116M
Xeris Pharmaceuticals Inc XERS:US $ 6.27M 1.38M
Zoetis ZTS:US $ 565M 31M